Exicure was founded by Chad A. Mirkin, C. Shad Thaxton, David A. Giljohann in 2011.

Who are Exicure's investors?

Exicure's investors include AbbVie, Purple Arch Ventures.

How much funding has Exicure raised?

Exicure has disclosed $33.6M raised across 3 of its 4 known rounds.

Where is Exicure headquartered?

Exicure is headquartered in Skokie, US.

Exicure

NASDAQ: XCUR

Skokie, US · Founded 2011 · Delaware corporation · 5 employees on LinkedIn · 3 known investors

Biotech

Founders & leadership

Exicure was founded in 2011 by Chad A. Mirkin, C. Shad Thaxton, and David A. Giljohann.

Chad A. MirkinCo-founder

C. Shad ThaxtonCo-founder

David A. GiljohanninCo-Founder, Exicure Inc.2011–2022

David S. SnyderinChief Financial Officer2014–2020Executive Officer at Coya Therapeutics

Percy Van Crocker, Jr.Vice President, Commercial Development

Board

Jay VenkatesanBoard director

Helen KimBoard director

David R. WaltBoard director

Investors · 3

AbbViereportedCambridge · $300K – $3M

Purple Arch VenturesreportedBoston

Also in the syndicate · 1

HiTron Systems

Funding

SEC filings, press & company announcements

$33.6M disclosed across 3 of 4 rounds · 2011–2024

Undisclosed amountequity financingDec 2024
HiTron Systems
Source ↗

▶$14.8MraisedOct 2015 · 16 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Chad A. MirkinDirector
C. Shad ThaxtonDirector
David A. GiljohannExecutive Officer, Director
Helen KimDirector
Jay VenkatesanDirector
David R. WaltDirector
David S. SnyderExecutive Officer

Amount sold: $14.8M
First sale: Oct 2015
Incorporated: Corporation, Delaware, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$13.4MraisedJun 2014 · 35 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Chad A. MirkinExecutive Officer, Director
C. Shad ThaxtonExecutive Officer, Director
David WaltDirector
David A. GiljohannExecutive Officer, Director
Jay VenkatesanDirector

Amount sold: $13.4M
Minimum investment: $50K
First sale: Jun 2014
Incorporated: Limited Liability Company, Delaware, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.4MraisedJan 2012 · 30 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Percy Van Crocker, Jr.Executive Officer
Chad A. MirkinExecutive Officer, Director
C. Shad ThaxtonExecutive Officer, Director

Amount sold: $5.4M
Minimum investment: $15K
First sale: Dec 2011
Incorporated: Limited Liability Company, Delaware, 2011
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Exicure says its cash won't fund the next 12 months of operationsstocktitan.net · Mar 2026

Exicure Secures $12M Strategic Investment as HiTron Systems Takes Majority Stake | Key Financing Deal | XCUR Stock Newsstocktitan.net · Dec 2024

Northwestern biotech spinout Exicure raises $11 million led by Luye Pharma Group - Crain's Chicago Businesschicagobusiness.com · Nov 2017

Exicure Closes Additional $11.2 Million in Private Financing to Advance Its Gene Regulatory and Immunotherapeutic Programs - BioSpacebiospace.com · Nov 2017

Nanotechnology Company Exicure Raises Over $42 Million from Bill Gates, AbbVie, Agilent and Others - BioSpacebiospace.com · Feb 2016

Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premiumcentralcharts.com

Frequently asked questions

Who founded Exicure?: Exicure was founded by Chad A. Mirkin, C. Shad Thaxton, David A. Giljohann in 2011.
Who are Exicure's investors?: Exicure's investors include AbbVie, Purple Arch Ventures.
How much funding has Exicure raised?: Exicure has disclosed $33.6M raised across 3 of its 4 known rounds.
Where is Exicure headquartered?: Exicure is headquartered in Skokie, US.